PHC-12-2015-1
PHC-12-2015-1
87 projects · €4,350,000 total EU contribution (project-level) · 88 participating organizations · 21 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€4,350,000
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (12)
- Germany (11)
- Spain (11)
- Italy (11)
- SE (8)
- France (6)
- IL (6)
- DK (4)
- AT (3)
- HU (3)
- IE (2)
- Netherlands (2)
- BE (1)
- BG (1)
- EE (1)
- FI (1)
- IS (1)
- NO (1)
- PT (1)
- SI (1)
- TR (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- AETHRA TELECOMMUNICATIONS1 projects · IT
- ACONET1 projects · IT
- ADAPTIX1 projects · UK
- BIFARMA1 projects · HU
- ALAM MEDICAL1 projects · FR
- ANANDA PHARMA1 projects · DE
- ANAXSYS TECHNOLOGY LTD1 projects · UK
- ANGIOTARGET BV1 projects · NL
- AROCELL AB1 projects · SE
- ATTOMARKER LIMITED1 projects · UK
- Atturos1 projects · IE
- AVERBIS GMBH1 projects · DE
Projects
Page 7 of 9
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
A breakthrough in Renal Cell Carcinoma: Personalized RCC-Test RCC-TEST · 710938 | H2020 | €50,000 | €71,429 | Details |
SmartMarker - Clinical Validation of Biomarkers by Smart Data Analyses SmartMarker · 685401 | H2020 | €50,000 | €71,429 | Details |
Continuous Diaphragm Monitoring for mechanically ventilated patients DiaMon · 718938 | H2020 | €50,000 | €71,429 | Details |
Profiling of tumour cells in blood for personalized treatment of metastatic cancer CYTOPRO · 697454 | H2020 | €50,000 | €71,429 | Details |
Electrodermal Orienting Reactivity-based Safeguard System for Early Detection of Suicide Propensity EDOR BOX · 717927 | H2020 | €50,000 | €71,429 | Details |
Tomosynthesis is a low-dose alternate to has CT already transformed Breast Imaging, our vision is to reduce the costs, further enhance sensitivity and reduce dose, and transform portability. Tomo-FPS · 697235 | H2020 | €50,000 | €71,429 | Details |
Neurological application validation for photon counting spectral CT NEUROSPECT · 685114 | H2020 | €50,000 | €71,429 | Details |
LeukoPredict: an in vitro system predicting and monitoring the therapeutic response of patients in the cure of Chronic Myeloid Leukemia (CML). LeukoPredict · 711286 | H2020 | €50,000 | €71,429 | Details |
Innovative diagnostic device for the early detection of diabetic neuropathy in diabetes patients INNODIAB · 683485 | H2020 | €50,000 | €71,429 | Details |
JUMPAIR: Decubitus Ulcers Diseases Diagnoses by means of Smart Anti-Decubitus System based on known Ulcers Activity Biomarkers JUMPAIR · 709595 | H2020 | €50,000 | €71,429 | Details |